Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with benzylthiouracil therapy: Report of the first case

Nephrology Dialysis Transplantation

Volumn 18, Issue 11, 2003, Pages 2421-2423

  Jarraya, Faiçal ^a   Abid, Mohamed ^a   Jlidi, Rachid ^a   Mkaouar, Khaled ^a   Mnif, Mouna ^a   Kharrat, Mahmoud ^a   Charfeddine, Khaled ^a   Kammoun, Khaoula ^a   Hmida, Mohamed Ben ^a   Hachicha, Jamil ^a  

^a HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

Acute renal failure; ANCA; Benzylthiouracil; Crescentic glomerulonephritis; Grave's disease

Indexed keywords

BENZYLTHIOURACIL; CARBIMAZOLE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; GRAVES DISEASE; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; LIVER TOXICITY; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; FEMALE; GLOMERULONEPHRITIS; HUMANS; PEROXIDASE; THIOURACIL;

EID: 10744220949     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg360     Document Type: Article

References (11)

1. Vogt BA, Youngki K, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 1994; 124: 986-988
2. Yuasa S, Hashimoto M, Yura T et al. Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy. Nephron 1996; 73: 701-703
3. Kitahara T, Hiromura K, Maezawa A et al. Case of propylthiouracil-induced vasculitis associated with antineutrophil cytoplasmic antibody (ANCA); review of literature. Clin Nephrol 1997; 47: 336-340
4. Kudoh Y, Kuroda S, Shimamoto K, Iimura O. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Clin Nephrol 1997; 48: 41-43
5. Harper L, Cokwell P, Savage COS. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant 1998; 13: 455-458
6. Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron 1996; 74: 734-735
7. D'Cruz D, Chesser AM, Lightowler C et al. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 1995; 34: 1090-1091
8. Dolman KM, Ganz ROB, Vervaat TJ et al. Vasculitis and antineutrophil cytoplasmic autoantibody associated with propylthiouracil therapy. Lancet 1993; 342: 651-652
9. Saeki T, Kuroda T, Mirota T, Suzuki K, Arakawa M, Kawazaki K. Significance of myeloperoxidase in rapidly progressive glomerulonephritis. Am J Kidney Dis 1995; 26: 13-21
10. Schmiederberg SV, Goebel C, Gleichmann E, Utrecht J. Neutrophils and drug metabolism. Science 1995; 268: 585-586
11. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266: 810-813